TRACEY MAYS: Open Payments
NPI 1780917443 · SOUTHAVEN, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$170 in 9 payments from 7 companies in 2025. Trend: 2023 $528 · 2024 $451 · 2025 $170
Food & beverage: $170
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $33 |
| Abbott Laboratories | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Amgen Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, Ozempic, FREESTYLE LIBRE 3, OTEZLA, Auvelity, MOUNJARO.
Industry payments across MS — which companies pay providers there.
